Showing results (331-340 of 352) with videos related to

Sort By:
Pageof 36
Gut|March 23, 2019
RSPO2 gene rearrangement: a powerful driver of β-catenin activation in liver tumoursThomas Longerich, Volker Endris, Olaf Neumann, et al.
Epidemics|November 5, 2021
Sustaining effective COVID-19 control in Malaysia through large-scale vaccinationPavithra Jayasundara, Kalaiarasu M Peariasamy, Kian Boon Law, et al.
Biology Direct|October 17, 2014
A new rhesus macaque assembly and annotation for next-generation sequencing analysesAleksey V Zimin, Adam S Cornish, Mnirnal D Maudhoo, et al.
Hepatology (Baltimore, Md.)|July 1, 2022
ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions in hereditary hemorrhagic telangiectasia of the liverChristian David Schmid, Victor Olsavszky, Manuel Reinhart, et al.
The Journal of Clinical Endocrinology and Metabolism|June 22, 2019
Transcriptome Profiling of Adipose Tissue Reveals Depot-Specific Metabolic Alterations Among Patients with Colorectal CancerMariam Haffa, Andreana N Holowatyj, Mario Kratz, et al.
JCI Insight|August 10, 2021
Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesisCarolin Czauderna, Alicia Poplawski, Colm J O'Rourke, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 9, 2018
SCYL1 variants cause a syndrome with low γ-glutamyl-transferase cholestasis, acute liver failure, and neurodegeneration (CALFAN)Dominic Lenz, Patricia McClean, Aydan Kansu, et al.
International Journal of Cancer|November 29, 2018
Application of patient-derived liver cancer cells for phenotypic characterization and therapeutic target identificationDarko Castven, Diana Becker, Carolin Czauderna, et al.
Cell Death and Differentiation|May 26, 2026
Fatty acid channelling into triglycerides and oxylipins drives ferroptosis resistance during oncogenic BRAF-induced senescenceMarkus S Hess, Kamal M Al-Shami, Carolina Dehesa Caballero, et al.
Pageof 36